Brendan Foley

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Global food ingredients, supply chains and integration planning are central to McCormick & Company’s combination with Unilever Foods as the business targets $600 million in synergies and builds a $20 billion global flavour platform. Representative image.

McCormick lays out growth priorities for $20bn Unilever Foods combination

McCormick targets $600m of synergies and faster global growth from its Unilever Foods combination, but integration will decide the $20bn platform's value.

byPallavi Madhiraju

September 13, 2026

Representative image of spices, sauces, condiments, and packaged foods illustrating the proposed Unilever Foods–McCormick deal, a $44.8 billion transaction that could create a global flavour powerhouse spanning seasonings, meal solutions, and branded food staples.

Unilever to combine Foods business with McCormick in $44.8bn deal to create global flavour powerhouse

Unilever to sell its $44.8bn Foods business to McCormick in a Reverse Morris Trust deal. Read what this means for ULVR shareholders and MKC's leverage.

bySrinath

March 31, 2026

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

McCormick lays out growth priorities for $20bn Unilever Foods combination

Unilever to combine Foods business with McCormick in $44.8bn deal to create global flavour powerhouse

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

SAMILBIO expands Chaeyun skincare with two November launches as K-beauty exports reach $11.1bn

Schneider Electric Infrastructure (SCHNEIDER) shares fall 3.5% despite new factory expansion: What will November results reveal?

Haleon (HLN) near 319p: Does a 15% share-price crash make its valuation attractive after the growth downgrade?

Ethan Allen will split CEO and chair roles, but who gets to choose Farooq Kathwari’s successor?